Summary & Overview
Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy with MCC: Inpatient Reimbursement Overview
DRG 739 addresses inpatient admissions for uterine and adnexa procedures for non-ovarian and non-adnexal malignancy with a Major Complication or Comorbidity, defining a higher-severity payment category. It matters for inpatient reimbursement because assignment to this Diagnosis-Related Group increases the Medicare Severity Diagnosis-Related Group payment to reflect greater resource consumption and complexity of care.
DRG 739 Overview
DRG 739 covers inpatient admissions for uterine and adnexa procedures performed for non-ovarian and non-adnexal malignancy when a Major Complication or Comorbidity is present. This Diagnosis-Related Group captures higher resource use due to the complexity of surgical management and the presence of serious comorbid conditions. It matters for Medicare payment because cases assigned to this Diagnosis-Related Group typically receive higher reimbursement to account for increased length of stay, intensive perioperative care, and additional diagnostic or therapeutic interventions. Accurate clinical documentation and coding determine assignment to this Diagnosis-Related Group and thus affect inpatient reimbursement.